Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endovascular therapeutic hypothermia adjunctive to percutaneous coronary intervention in acute myocardial infarction: realistic simulation as a game changer.
Dallan LAP, Dae M, Giannetti NS, Polastri TF, Lima MKF, Rochitte CE, Hajjar LA, San Martin CYB, Lima FG, Nicolau JC, de Oliveira MT Jr, Dallan LAO, Ribeiro da Silva EE, Kalil Filho R, Abizaid A, Lemos Neto PA, Timerman S. Dallan LAP, et al. Among authors: abizaid a. Rev Cardiovasc Med. 2022 Mar 16;23(3):104. doi: 10.31083/j.rcm2303104. Rev Cardiovasc Med. 2022. PMID: 35345271 Free article.
Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
Dudek D, Dziewierz A, Brener SJ, Abizaid A, Merkely B, Costa RA, Bar E, Rakowski T, Kornowski R, Dressler O, Abizaid A, Silber S, Stone GW. Dudek D, et al. Among authors: abizaid a. Circ Cardiovasc Interv. 2015 Feb;8(2):e001484. doi: 10.1161/CIRCINTERVENTIONS.114.001484. Circ Cardiovasc Interv. 2015. PMID: 25603802 Clinical Trial.
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.
Kandzari DE, Kirtane AJ, Windecker S, Latib A, Kedhi E, Mehran R, Price MJ, Abizaid A, Simon DI, Worthley SG, Zaman A, Choi JW, Caputo R, Kanitkar M, McLaurin B, Potluri S, Smith T, Spriggs D, Tolleson T, Nazif T, Parke M, Lee LC, Lung TH, Stone GW; Onyx ONE US/Japan Investigators. Kandzari DE, et al. Among authors: abizaid a. Circ Cardiovasc Interv. 2020 Nov;13(11):e009565. doi: 10.1161/CIRCINTERVENTIONS.120.009565. Epub 2020 Nov 10. Circ Cardiovasc Interv. 2020. PMID: 33167705 Free PMC article.
Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.
Abizaid A, Campos CM, Guimarães PO, Costa JR Jr, Falcão BAA, Mangione F, Caixeta A, Lemos PA, de Brito FS Jr, Cavalcante R, Bezerra CG, Cortes L, Ribeiro HB, de Souza FR, Huemer N, do Val RM, Caramelli B, Calderaro D, Lima FG, Hajjar LA, Mehran R, Filho RK; COVID MI investigators. Abizaid A, et al. Catheter Cardiovasc Interv. 2021 Sep;98(3):E370-E378. doi: 10.1002/ccd.29709. Epub 2021 Apr 27. Catheter Cardiovasc Interv. 2021. PMID: 33904638 Free PMC article.
Seattle Angina Pectoris Questionnaire and Canadian Cardiovascular Society Angina Categories in the Assessment of Total Coronary Atherosclerotic Burden.
Guimarães WVN, Nicz PFG, Garcia-Garcia HM, Abizaid A, Santos LM, Rosa VE, Ribeiro MH, Mehta S, Ribeiro E, Lemos PA, Brito FS Jr, Hajjar L, Filho RK, Campos CM. Guimarães WVN, et al. Among authors: abizaid a. Am J Cardiol. 2021 Aug 1;152:43-48. doi: 10.1016/j.amjcard.2021.04.029. Epub 2021 Jun 24. Am J Cardiol. 2021. PMID: 34175106
High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort study.
Guimarães PO, de Souza FR, Lopes RD, Bittar C, Cardozo FA, Caramelli B, Calderaro D, Albuquerque CP, Drager LF, Feres F, Baracioli L, Feitosa Filho G, Barbosa RR, Ribeiro HB, Ribeiro E, Alves RJ, Soeiro A, Faillace B, Figueiredo E, Damiani LP, do Val RM, Huemer N, Nicolai LG, Hajjar LA, Abizaid A, Kalil Filho R. Guimarães PO, et al. Among authors: abizaid a. Int J Cardiol Heart Vasc. 2021 Oct;36:100853. doi: 10.1016/j.ijcha.2021.100853. Epub 2021 Jul 30. Int J Cardiol Heart Vasc. 2021. PMID: 34345648 Free PMC article.
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years.
Haude M, Toelg R, Lemos PA, Christiansen EH, Abizaid A, von Birgelen C, Neumann FJ, Wijns W, Ince H, Kaiser C, Lim ST, Escaned J, Eeckhout E, Garcia-Garcia HM, Waksman R. Haude M, et al. Among authors: abizaid a. Cardiovasc Revasc Med. 2022 May;38:106-110. doi: 10.1016/j.carrev.2021.07.017. Epub 2021 Jul 22. Cardiovasc Revasc Med. 2022. PMID: 34364807
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
Kandzari DE, Kirtane AJ, Mehran R, Price MJ, Simon DI, Latib A, Kedhi E, Abizaid A, Worthley SG, Zaman A, Hudec M, Stoler R, Choi JW, Kanitkar M, Conradie A, Tam CF, Walton A, Gruberg L, Ando K, Lee LC, Lung TH, Windecker S, Stone GW. Kandzari DE, et al. Among authors: abizaid a. Catheter Cardiovasc Interv. 2022 Feb;99(3):583-592. doi: 10.1002/ccd.29939. Epub 2021 Sep 3. Catheter Cardiovasc Interv. 2022. PMID: 34478233
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.
Cavender MA, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL; CHAMPION PHOENIX Investigators*. Cavender MA, et al. Circ Cardiovasc Interv. 2022 Jan;15(1):e010390. doi: 10.1161/CIRCINTERVENTIONS.120.010390. Epub 2021 Dec 17. Circ Cardiovasc Interv. 2022. PMID: 34915723 Free PMC article. Clinical Trial.
Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials.
Campos CM, Mehran R, Capodanno D, Owen R, Windecker S, Varenne O, Stone GW, Valgimigli M, Hajjar LA, Kalil Filho R, Oldroyd K, Morice MC, Urban P, Abizaid A. Campos CM, et al. Among authors: abizaid a. Circ Cardiovasc Interv. 2024 Apr;17(4):e013000. doi: 10.1161/CIRCINTERVENTIONS.122.013000. Epub 2024 Apr 16. Circ Cardiovasc Interv. 2024. PMID: 38626080
497 results